Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Hospitalized patients with atrial fibrillation compared to those included in recent trials on novel oral anticoagulants: a population-based study.

Joppi R, Cinconze E, Mezzalira L, Pase D, Poggiani C, Rossi E, Pengo V; Italian Horizon Scanning Project.

Eur J Intern Med. 2013 Jun;24(4):318-23. doi: 10.1016/j.ejim.2013.02.018. Epub 2013 Mar 23.

PMID:
23528931
2.

Outcomes, health costs and use of antiplatelet agents in 7,082 patients admitted for an acute coronary syndrome occurring in a large community setting.

Maggioni AP, Rossi E, Cinconze E, Roggeri DP, Roggeri A, Fabbri G, De Rosa M; ARNO Cardiovascular Observatory.

Cardiovasc Drugs Ther. 2013 Aug;27(4):333-40. doi: 10.1007/s10557-013-6455-z.

PMID:
23519685
3.

Direct healthcare costs and resource consumption after acute coronary syndrome: a real-life analysis of an Italian subpopulation.

Roggeri DP, Roggeri A, Rossi E, Cinconze E, De Rosa M, Maggioni AP; ARNO Cardiovascular Observatory.

Eur J Prev Cardiol. 2014 Sep;21(9):1090-6. doi: 10.1177/2047487313483608. Epub 2013 Mar 20.

PMID:
23515447
4.

The direct economic cost of pharmacologically-treated diabetes in Italy-2006. The ARNO observatory.

Marchesini G, Forlani G, Rossi E, Berti A, De Rosa M; ARNO Working Group.

Nutr Metab Cardiovasc Dis. 2011 May;21(5):339-46. doi: 10.1016/j.numecd.2009.10.009. Epub 2010 Feb 13.

PMID:
20153612
5.

Hypoglycemia caused by maprotiline in a patient taking oral antidiabetics.

Zogno MG, Tolfo L, Draghi E.

Ann Pharmacother. 1994 Mar;28(3):406. No abstract available.

PMID:
8193439

Supplemental Content

Loading ...
Support Center